103 related articles for article (PubMed ID: 6428200)
41. A double blind comparative study of tegafur (FT) and UFT (a combination of Tegafur and uracil) in advanced breast cancer.
Tashiro H; Nomura Y; Ohsaki A
Jpn J Clin Oncol; 1994 Aug; 24(4):212-7. PubMed ID: 8072200
[TBL] [Abstract][Full Text] [Related]
42. Phase II study of co-administration of uracil and tegafur (UFT) in hepatocellular carcinoma. Tokyo Liver Cancer Chemotherapy Study Group.
Jpn J Clin Oncol; 1985 Sep; 15(3):559-62. PubMed ID: 2997511
[TBL] [Abstract][Full Text] [Related]
43. [Phase II study of 5'-DFUR (Furtulon) capsule for bladder cancer].
Kubota Y; Miura T; Shuin T; Kinoshita Y; Hosaka M; Kondo I; Moriyama M; Fukushima S; Fukuoka H; Miyai K
Gan To Kagaku Ryoho; 1991 Oct; 18(13):2301-6. PubMed ID: 1834023
[TBL] [Abstract][Full Text] [Related]
44. Adjuvant therapy with 5-fluoro-1-(2-tetrahydrofuryl)-2,4 (1H,3H)-pyrimidinedione (UFT) and Bestatin in patients with transitional cell carcinoma of the bladder--comparison between UFT therapy alone and UFT therapy in combination with Bestatin.
Uchibayashi T; Kunimi K; Yamamoto H; Koshida K
Int J Clin Pharmacol Ther; 1995 Aug; 33(8):465-8. PubMed ID: 8556228
[TBL] [Abstract][Full Text] [Related]
45. [Progress in oral anti-cancer drug therapy for urological cancer].
Tsukamoto S; Akaza H
Gan To Kagaku Ryoho; 1999 Feb; 26(3):308-14. PubMed ID: 10065093
[TBL] [Abstract][Full Text] [Related]
46. [Complete remission of lung metastases of bladder tumor treated by small dosage of UFT: a case report].
Fukuoka H; Takeda M; Nomura S; Ogawa T; Sakanishi S
Hinyokika Kiyo; 1991 May; 37(5):541-4. PubMed ID: 1858591
[TBL] [Abstract][Full Text] [Related]
47. [An elderly patient with advanced gastric cancer maintaining complete response for over 3 years by oral administration of UFT following short span of S-1].
Yamanaka T; Okabe K; Sugiyama S; Sano O; Wada A; Beppu T; Baba H
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2424-6. PubMed ID: 21224594
[TBL] [Abstract][Full Text] [Related]
48. Tegafur-uracil (UFT) plus folinic acid in advanced rectal cancer.
Sanchiz F; Milla A
Jpn J Clin Oncol; 1994 Dec; 24(6):322-6. PubMed ID: 7830337
[TBL] [Abstract][Full Text] [Related]
49. [Neoadjuvant chemotherapy with nedaplatin and UFT for oral squamous cell carcinomas].
Fujimori S; Kurita H; Azegami T; Koike T; Ohtsuka A; Kobayashi H; Tanaka K; Kurashina K
Gan To Kagaku Ryoho; 2003 May; 30(5):647-52. PubMed ID: 12795096
[TBL] [Abstract][Full Text] [Related]
50. Phase I trial of Orzel (UFT plus leucovorin), cisplatin, and radiotherapy in the treatment of potentially resectable esophageal cancer.
Tedesco KL; Berlin J; Blanke CD; Teng M; Choy H; Roberts J; Beauchamp RD; Leach S; Wyman K; Tarpley J; Shyr Y; Caillouette C; Chakravarthy B
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1364-70. PubMed ID: 15817338
[TBL] [Abstract][Full Text] [Related]
51. [Effect of UFT on urinary bladder tumors in rats induced by N-butyl-N-(4-hydroxybutyl)nitrosamine].
Samma S; Tabata S; Nakatsuji F; Yoshie T; Moriya A; Matsuki H; Watanabe S; Babaya K; Hirao Y; Okajima E
Gan To Kagaku Ryoho; 1985 Aug; 12(8):1661-8. PubMed ID: 3927848
[TBL] [Abstract][Full Text] [Related]
52. A phase I study of UFT/leucovorin, carboplatin, and paclitaxel in combination with external beam radiation therapy for advanced esophageal carcinoma.
Czito BG; Cohen DP; Kelsey CR; Lockhart AC; Bendell JC; Willett CG; Petros WP; D'Amico TA; Truax R; Hurwitz HI
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1066-72. PubMed ID: 17881149
[TBL] [Abstract][Full Text] [Related]
53. High-dose oral tegafur-uracil maintenance therapy in patients with uterine cervical cancer.
Sakaguchi I; Motohara T; Saito F; Takaishi K; Fukumatsu Y; Tohya T; Shibata S; Mimori H; Tashiro H; Katabuchi H
J Gynecol Oncol; 2015 Jul; 26(3):193-200. PubMed ID: 25686399
[TBL] [Abstract][Full Text] [Related]
54. [Antineoplastic effect of UFT therapy (uracil-FT-207 combination therapy) on experimental pancreatic cancer transplanted in the pancreas and subcutaneous region].
Ohyama K; Koike D; Odake Y; Takiyama Y; Saitoh T; Kagaya T; Takebe T; Ishii K
Gan To Kagaku Ryoho; 1982 Dec; 9(12):2168-74. PubMed ID: 6307180
[TBL] [Abstract][Full Text] [Related]
55. [Clinical evaluation of chemohormonal therapy as an initial treatment for stage D2 prostatic cancer--effect of UFT administration combined with hormonal therapy].
Honda M; Takasaki E; Suzuki T; Maeda S; Imai T; Hosoya Y; Chen JA
Gan To Kagaku Ryoho; 1995 Jan; 22(1):105-9. PubMed ID: 7826063
[TBL] [Abstract][Full Text] [Related]
56. [Combination chemotherapy with tegafur-uracil (UFT) and cisplatin (CDDP) for advanced gastric cancer. UFTP Study Group].
Sato A; Hasegawa K; Kurihara M; Takahashi M; Akazawa S; Fukuyama Y; Koizumi W; Hayakawa M; Sasai T; Kimura K
Gan To Kagaku Ryoho; 1995 Sep; 22(10):1355-62. PubMed ID: 7668870
[TBL] [Abstract][Full Text] [Related]
57. Phase II trial of epirubicin, cisplatin, oral uracil and tegafur, and leucovorin in patients with advanced gastric carcinoma.
Jeen YT; Yoon SY; Shin SW; Kim BS; Mok YJ; Kim CS; Hyun JH; Kim JS; Kim YH
Cancer; 2001 Jun; 91(12):2288-93. PubMed ID: 11413517
[TBL] [Abstract][Full Text] [Related]
58. [Cooperative research of UFT E phase II study. Cooperative Study Group of UFT E in Tohoku Area].
Kikuchi K; Wakui A
Gan To Kagaku Ryoho; 1990 Nov; 17(11):2183-90. PubMed ID: 2241182
[TBL] [Abstract][Full Text] [Related]
59. Concentration of 5-fluorouracil in renal cells from cancer patients administered a mixture of 1-(2-tetrahydrofuryl)-5-fluorouracil and uracil.
Fujita K; Munakata A
Int J Clin Pharmacol Res; 1991; 11(4):171-4. PubMed ID: 1813435
[TBL] [Abstract][Full Text] [Related]
60. Uracil-Tegafur-induced pleural effusion following lung cancer surgery.
Goto T; Maeshima A; Oyamada Y; Wakaki M; Hamaguchi R; Kato R
Ann Thorac Cardiovasc Surg; 2010 Aug; 16(4):281-5. PubMed ID: 21057448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
